| BIOHAVEN PHARMACEUTICALS, INC. | DLA PIPER LLP (US) | Q3 2026 | Health Issues |
| TAE TECHNOLOGIES, INC. | DLA PIPER LLP (US) | Q3 2026 | Energy/Nuclear |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | DLA PIPER LLP (US) | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Medicare/Medicaid |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | DLA PIPER LLP (US) | Q3 2026 | Education |
| PIVOTAL HEALTH | DLA PIPER LLP (US) | Q3 2026 | Health Issues |
| GALDERMA LABORATORIES, L.P. | DLA PIPER LLP (US) | Q3 2026 | Trade (domestic/foreign), Pharmacy |
| BIOGEN, INC. | DLA PIPER LLP (US) | Q3 2026 | Trade (domestic/foreign), Medical/Disease Research/Clinical Labs, Taxation/Internal Revenue Code |
| RESEARCH SOCIETY ON ALCOHOL | DLA PIPER LLP (US) | Q3 2026 | Alcohol and Drug Abuse, Budget/Appropriations |
| THE JED FOUNDATION | DLA PIPER LLP (US) | Q3 2026 | Education, Health Issues |
| UNITED WAY WORLDWIDE | DLA PIPER LLP (US) | Q3 2026 | Disaster Planning/Emergencies, Health Issues, Housing |
| THE NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES | DLA PIPER LLP (US) | Q3 2026 | Medicare/Medicaid, Health Issues, Budget/Appropriations |
| WISCONSIN PHYSICIANS SERVICE INSURANCE CORPORATION (DBA WPS HEALTH SOLUTIONS) | DLA PIPER LLP (US) | Q3 2026 | Defense, Veterans, Health Issues |
| DUKE UNIVERSITY | DLA PIPER LLP (US) | Q3 2026 | Taxation/Internal Revenue Code, Education |
| STAX ENGINEERING, INC. | DLA PIPER LLP (US) | Q3 2026 | Environment/Superfund |
| TTX COMPANY | DLA PIPER LLP (US) | Q3 2026 | Railroads |
| CORVENT MEDICAL, INC. | DLA PIPER LLP (US) | Q3 2026 | Defense, Veterans, Health Issues |
| XEROX HOLDINGS CORPORATION | DLA PIPER LLP (US) | Q3 2026 | Pharmacy |
| BOSTON DYNAMICS, INC. | DLA PIPER LLP (US) | Q3 2026 | Manufacturing |
| MANHATTAN ASSOCIATES, INC. | DLA PIPER LLP (US) | Q3 2026 | Homeland Security |
| NOVARTIS | DLA PIPER LLP (US) | Q3 2026 | Trade (domestic/foreign), Medical/Disease Research/Clinical Labs, Taxation/Internal Revenue Code |
| CROWDSTRIKE, INC. | DLA PIPER LLP (US) | Q3 2026 | Homeland Security |
| REGENXBIO INC. | DLA PIPER LLP (US) | Q3 2026 | Medical/Disease Research/Clinical Labs, Health Issues |
| AVALYN PHARMA INC. | DLA PIPER LLP (US) | Q3 2026 | Medical/Disease Research/Clinical Labs, Health Issues |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) | DLA PIPER LLP (US) | Q3 2026 | Medicare/Medicaid, Medical/Disease Research/Clinical Labs |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | DLA PIPER LLP (US) | Q3 2026 | Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Pharmacy |
| RAINFALL HEALTH | DLA PIPER LLP (US) | Q3 2026 | Medicare/Medicaid |
| PONYA DIAGNOSTICS, LLC | DLA PIPER LLP (US) | Q2 2026 | Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Health Issues |
| MICHAELS STORES, INC. | DLA PIPER LLP (US) | Q2 2026 | Trade (domestic/foreign), Tariff (miscellaneous tariff bills) |
| PARTICULA GROUP INC. | DLA PIPER LLP (US) | Q2 2026 | Financial Institutions/Investments/Securities |
| AIDOC, INC. | DLA PIPER LLP (US) | Q1 2026 | Medicare/Medicaid, Health Issues |
| ASSOCIATION OF AMERICAN UNIVERSITIES | DLA PIPER LLP (US) | Q1 2026 | Education |
| INDIVIOR INC. | DLA PIPER LLP (US) | Q1 2026 | Medicare/Medicaid, Health Issues |
| IRHYTHM TECHNOLOGIES, INC. | DLA PIPER LLP (US) | Q1 2026 | Medicare/Medicaid |
| CALIFORNIA APARTMENT ASSOCIATION | DLA PIPER LLP (US) | Q4 2025 | Pharmacy |
| OPENAI OPCO, LLC | DLA PIPER LLP (US) | Q2 2025 | Computer Industry |